References
- Petri M. Epidemiology of systemic lupus erythematosus. Best Pract Res Clin Rheumatol 2002; 16: 847–58
- Doria A., Rinaldi S., Ermani M., Salaffi F., Iaccarino L., Ghirardello A., et al. Health‐related quality of life in Italian patients with systemic lupus erythematosus. II. Role of clinical, immunological and psychological determinants. Rheumatology (Oxford) 2004; 43: 1580–6
- Rinaldi S., Doria A., Salaffi F., Ermani M., Iaccarino L., Ghirardello A., et al. Health‐related quality of life in Italian patients with systemic lupus erythematosus. I. Relationship between physical and mental dimension and impact of age. Rheumatology (Oxford) 2004; 43: 1574–9
- Ruperto N., Buratti S., Duarte‐Salazar C., Pistorio A., Reiff A., Bernstein B., et al. Health‐related quality of life in juvenile‐onset systemic lupus erythematosus and its relationship to disease activity and damage. Arthritis Rheum 2004; 51: 458–64
- Wang C., Mayo N. E., Fortin P. R. The relationship between health related quality of life and disease activity and damage in systemic lupus erythematosus. J Rheumatol 2001; 28: 525–32
- Jolly M., Utset T. O. Can disease specific measures for systemic lupus erythematosus predict patients health related quality of life?. Lupus 2004; 13: 924–6
- Gladman D. D., Urowitz M. B., Gough J., MacKinnon A. Fibromyalgia is a major contributor to quality of life in lupus. J Rheumatol 1997; 24: 2145–8
- Hanly J. G. Disease activity, cumulative damage and quality of life in systematic lupus erythematosus: results of a cross‐sectional study. Lupus 1997; 6: 243–7
- Stoll T., Gordon C., Seifert B., Richardson K., Malik J., Bacon P. A., et al. Consistency and validity of patient administered assessment of quality of life by the MOS SF‐36; its association with disease activity and damage in patients with systemic lupus erythematosus. J Rheumatol 1997; 24: 1608–14
- Karlson E. W., Daltroy L. H., Lew R. A., Wright E. A., Partridge A. J., Fossel A. H., et al. The relationship of socioeconomic status, race, and modifiable risk factors to outcomes in patients with systemic lupus erythematosus. Arthritis Rheum 1997; 40: 47–56
- Fortin P. R., Abrahamowicz M., Neville C., du Berger R., Fraenkel L., Clarke A. E., et al. Impact of disease activity and cumulative damage on the health of lupus patients. Lupus 1998; 7: 101–7
- Mok C. C., Mak A., Chu W. P., To C. H., Wong S. N. Long‐term survival of southern Chinese patients with systemic lupus erythematosus: a prospective study of all age‐groups. Medicine (Baltimore) 2005; 84: 218–24
- Mok C. C., Ho C. T., Wong R. W., Lau C. S. Damage accrual in southern Chinese patients with systemic lupus erythematosus. J Rheumatol 2003; 30: 1513–19
- Ware J. E., Jr, Sherbourne C. D. The MOS 36‐item Short‐Form Health Survey (SF‐36). 1. Conceptual framework and item selection. Med Care 1992; 30: 473–81
- McHorney C., Ware J. E., Raczek A. The MOS 36‐item Short‐Form Health Survey. II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993; 31: 247–63
- Buyon J. P., Petri M. A., Kim M. Y., Kalunian K. C., Grossman J., Hahn B. H., et al. The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial. Ann Intern Med 2005; 142: 953–62
- Gladman D., Ginzler E., Goldsmith C., Fortin P., Liang M., Urowitz M., et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index for systemic lupus erythematosus. Arthritis Rheum 1996; 39: 363–9
- Tan E. M., Cohen A. S., Fries J. F., Masi A. T., McShane D. J., Rothfield N. F., et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271–7